ds to be directed towards the development of age-appropriate healthcare, a long-term care policy, and mechanisms for ensuring, as a right, the social protection of older persons."
Prince adds, "Later this year, ADI will launch the first World Alzheimer Report alerting governments, policymakers and donors of the urgent need to give priority to these actions."
Can Lifestyle Prevent Alzheimer's?
Henry Brodaty, MD, DSc, Professor of Age Care Mental Health and Director of the Dementia Collaborative Research Centre at the University of New South Wales, Australia, will present a plenary talk on "Can lifestyle prevent Alzheimer's disease?" on Friday morning, March 27, 2009. He will directly address whether we can really "eat, drink, exercise, socialize and think our way out of Alzheimer's."
In recent years, there has been a great deal of conflicting information in this area. Research studies have reported protective effects against Alzheimer's and dementia for education; exercise; mental activities; foods and fluids rich in antioxidants and polyphenols such as fruit or vegetable juice, wine, green tea, and fish; and long-term use of certain medications, including non-steroidal anti-inflammatory drugs, anti-cholesterol drugs and hormone replacement therapy.
On the other hand, high blood pressure, type II diabetes, obesity, high fat diets, high cholesterol, head injury, loneliness, lack of education, lack of exercise, depression, low birth weight for gestational age, and smaller head circumference have been found to be risk factors for Alzheimer's and dementia.
Brodaty's bottom line, "There is currently no absolute prevention against Alzheimer's. Until reports are confirmed by several groups around the world, consumers should be wary of media hyperbole. And, even where a risk or protective factor is significant in a large population study, this may only cha
Page: 1 2 3 4 5 6 Related medicine technology :1
|SOURCE Alzheimer's Disease International|
Copyright©2009 PR Newswire.
All rights reserved
. Idenix Pharmaceuticals and GlaxoSmithKline Sign Worldwide License Agreement for IDX899, a Novel NNRTI for the Treatment of HIV2
. Copper Eliminates Resistant Hospital Germs in a Worldwide Field Test3
. Sonablate(R) International HIFU Registry is the First Worldwide HIFU Clinical Registry for Prostate Cancer Treatments4
. BBK Worldwide Celebrates 25th Anniversary of Industry Leadership Through Innovation in Patient Enrollment5
. Orion Genomics Gains Exclusive Worldwide Rights to the IGF2 Gene for Colorectal Cancer Risk Testing Through Licensing Agreement With Johns Hopkins University6
. Video: The Arizona Heart Institute Announces the Largest Worldwide Experience with Endoluminal Grafting to Treat Thoracic Aortic Aneurysms and Related Pathologies7
. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development8
. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology9
. A Worldwide Phase III Clinical Trial Seeks U.S. Patients to Explore Investigational Drug Phenoxodiol10
. New Analysis Estimates Numbers of Older U.S. Adults Who May Benefit From Statin Therapy11
. Physicians Estimate That if Approved, Ceftobiprole Will Steal Nearly a Third of Zyvoxs Patient Share in the Treatment of Nosocomial Pneumonia